title: Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.
abstract: Rotavirus is the leading cause of severe diarrhea disease in newborns and young children worldwide with approximately 300,000 pre-adolescent deaths each year. Quillaja saponins are a natural aqueous extract obtained from the Chilean soapbark tree. The extract is approved for use in humans by the FDA for use in beverages as a food addictive. We have demonstrated that Quillaja extracts have strong antiviral activities in vitro against six different viruses. In this study, we evaluated the in vivo antiviral activity of these extracts against rhesus rotavirus (RRV) using a mouse model. We established that at a dosage of 0.015 mg/mouse of saponin extract, RRV induced diarrhea can be significantly reduced from 79% to 11% when mice are exposed to 500 plaque-forming-units (PFU) for each of five consecutive days. Additionally, while a reduction of RRV induced diarrhea depended both on the concentration of virus introduced and on the amount of Quillaja extract given to each mouse, the severity and interval of diarrhea under a variety of conditions tested, in all the treated mice were greatly reduced when compared to those that did not receive the Quillaja extracts. Mechanistically, there is strong evidence that the Quillaja extracts are able to "block" rotavirus infection by inhibiting virus-host attachment through disruption of cellular membrane proteins and/or virus receptors. We believe that Quillaja extracts have promise as antivirals to reduce rotavirus infection and the severity of the disease in humans.
authors.affiliation: The University of Texas Arlington, Department of Biology, Arlington, TX 76019, USA. uxr5@cdc.gov
authors.forename: Ka Ian
authors.initials: KI
authors.lastname: Tam
authors.forename: Michael R
authors.initials: MR
authors.lastname: Roner
mesh_terms: D000818:Animals; D002460:Cell Line; D003967:Diarrhea / Q000188:drug therapy / Q000821:virology; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects; D031990:Quillaja / Q000737:chemistry*; D012401:Rotavirus / Q000187:drug effects* / Q000502:physiology; D012400:Rotavirus Infections / Q000188:drug therapy / Q000821:virology*; D012503:Saponins / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D010936:Plant Extracts; D012503:Saponins